secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001493152-25-000246
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics receives Nasdaq bid price deficiency notice; 180-day cure period until June 30, 2025
--------------------------------------------------------------------------------

- Notice received December 30, 2024: closing bid price below $1 for 30 consecutive business days.
- Company has until June 30, 2025 to regain compliance for 10 consecutive business days.
- If not cured, may request a second 180-day period if other listing standards are met.
- Stock continues to trade on Nasdaq under symbol ERNA with no immediate delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315225000246/0001493152-25-000246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315225000246/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-000246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer